Document is current

Any future updates will be listed below

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

Crossref DOI link: https://doi.org/10.1186/s13045-016-0344-4

Published Online: 2016-10-24

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark